Radiopharm Theranostics Limited (RADX:NASDAQ) closed at $1.01 on October 23, 2026, up 6.32% on the day. The stock trades 93.8% below its 52-week high of $16.25 and 12.2% above its 52-week low of $0.900. Over the past year, it lost 81.1%. Radiopharm Theranostics Limited is part of the Health Care sector.
In 252 trading sessions since October 23, 2025, RADX closed higher on 106 days (42%). Its best day was December 15, 2025 (+149.53%) and its worst was December 16, 2025 (-43.65%). The stock moved 10% or more in a single session 8 times. It opened at least 5% above the previous day's high 4 times.
Radiopharm Theranostics Limited engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas of high unmet medical needs. It is developing its lead products comprising Nano-mAbs and AVB6 Integrin.
Find more stocks like RADX with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.